ACIU
AC Immune SA
NASDAQ · Healthcare · Biotechnology · CH
$2.20
+5.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 8.93x
- P/E 2028E
- 4.88x
- P/S forward
- 91.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.10x
- Price / sales
- 10.24x
- Price / cash flow
- -5.15x
Enterprise value
- Enterprise value
- $131.8M
- EV / sales
- 6.17x
- EV / EBITDA
- -2.59x
- EV / EBIT
- -2.45x
- Market cap
- $218.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026